[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Campa
P P
PP
II Cattedra di Cardiologia, Università degli Studi, La Sapienza, Roma.
Puddu
P E
PE
Schiariti
M
M
Monti
F
F
Dawodu
A A
AA
Gentile
C
C
Lilla Della Monica
P L
PL
Vaccaro
M
M
De Biase
L
L
D000322:Adrenergic Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D003846:Deoxyepinephrine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009566:Nitrates / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000322:Adrenergic Agonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D016861:Cyclooxygenase Inhibitors; D004071:Digitalis Glycosides; D004232:Diuretics; D018491:Dopamine Agonists; D009566:Nitrates; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D004280:Dobutamine; C023487:ibopamine; D003846:Deoxyepinephrine; D004298:Dopamine